ST Sansheng will strip concrete assets

On March 4, ST Sansheng announced that the company's Draft Restructuring Agreement and Restructuring Plan had been approved by the second creditors'meeting of pre-reorganization.

Previously, the draft was approved by the investor group meeting and the first provisional shareholders'meeting in 2025 on January 24. The Company stated that, in accordance with the relevant laws and regulations, given that the "Restructuring Agreement and Restructuring Plan Draft" has been passed by voting, the Company will subsequently apply to the court for reorganisation; if the court decides to accept the reorganisation, the Company will do a good job of reorganisation in accordance with the law and regulations.

According to the reorganization plan, ST Sansheng will strip concrete assets, retain the existing Chongqing Chunrui Pharmaceutical and Jilin Liaoyuan Baikang Company, and timely inject Hebei Jiheng Pharmaceutical Industry, a new owner of Hebei Private Enterprise Jiheng Group.